-
Je něco špatně v tomto záznamu ?
Gas chromatographic-mass spectrometric analysis of biomarkers related to folate and cobalamin status in human serum after dimercaptopropanesulfonate reduction and heptafluorobutyl chloroformate derivatization
Šimek P., Hušek P., Zahradníčková H.
Jazyk angličtina Země Spojené státy americké
- MeSH
- biologické markery MeSH
- financování organizované MeSH
- formiáty MeSH
- homocystein analýza MeSH
- kyselina listová krev MeSH
- kyselina methylmalonová analýza MeSH
- kyseliny alkansulfonové MeSH
- lidé MeSH
- oxidace-redukce MeSH
- plynová chromatografie s hmotnostně spektrometrickou detekcí metody normy MeSH
- sulfhydrylové sloučeniny chemie MeSH
- vitamin B 12 krev MeSH
- Check Tag
- lidé MeSH
Methylmalonic acid and total homocysteine belong to useful clinical indicators of cobalamin and folate status and are commonly measured separately. A sensitive and rapid method has been developed for simultaneous determination of both biomarkers and related metabolites in serum or plasma by isotope dilution gas chromatography-mass spectrometry (GC/MS). Thiols bound in disulfide bonds were released with 2,3-dimercapto-1-propanesulfonic acid (DMPS), and after deproteinization, they were phase-transfer derivatized with heptafluorobutyl chloroformate (HFBCF) in a single step. The reducing capability of the DMPS agent was comparable to that of the dithiothreitol, but exceeded the latter in much cleaner extracts obtained. The new method enabled GC/MS screening of amino acidic metabolites, including cystathionine and thiol-containing dipeptides, as their N(S,O)-heptafluorobutoxycarbonyl heptafluorobutyl ester derivatives in serum or plasma. Accurate quantitation of seven biomarkers was accomplished by using deuterated internal standards; the detection limits ranged from 7 to 20 nmol/L, the between-day precision from 1.5 to 8.8%, and the recoveries were between 83 and 103%. The results suggest that the new combined procedure of DMPS reduction and HFBCF derivatization make the method efficient for diagnostics of folate and cobalamin status as well as for screening of amino acidic metabolites in body fluids.
- 000
- 03408naa 2200505 a 4500
- 001
- bmc11005906
- 003
- CZ-PrNML
- 005
- 20130129163135.0
- 008
- 110324s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Šimek, Petr, $d 1960- $7 xx0081986
- 245 10
- $a Gas chromatographic-mass spectrometric analysis of biomarkers related to folate and cobalamin status in human serum after dimercaptopropanesulfonate reduction and heptafluorobutyl chloroformate derivatization / $c Šimek P., Hušek P., Zahradníčková H.
- 314 __
- $a Biology Centre, Laboratory of Analytical Biochemistry, Academy of Sciences of the Czech Republic, Branisovská 31, CZ-370 05 Ceské Budejovice, Czech Republic. simek@bclab.eu
- 520 9_
- $a Methylmalonic acid and total homocysteine belong to useful clinical indicators of cobalamin and folate status and are commonly measured separately. A sensitive and rapid method has been developed for simultaneous determination of both biomarkers and related metabolites in serum or plasma by isotope dilution gas chromatography-mass spectrometry (GC/MS). Thiols bound in disulfide bonds were released with 2,3-dimercapto-1-propanesulfonic acid (DMPS), and after deproteinization, they were phase-transfer derivatized with heptafluorobutyl chloroformate (HFBCF) in a single step. The reducing capability of the DMPS agent was comparable to that of the dithiothreitol, but exceeded the latter in much cleaner extracts obtained. The new method enabled GC/MS screening of amino acidic metabolites, including cystathionine and thiol-containing dipeptides, as their N(S,O)-heptafluorobutoxycarbonyl heptafluorobutyl ester derivatives in serum or plasma. Accurate quantitation of seven biomarkers was accomplished by using deuterated internal standards; the detection limits ranged from 7 to 20 nmol/L, the between-day precision from 1.5 to 8.8%, and the recoveries were between 83 and 103%. The results suggest that the new combined procedure of DMPS reduction and HFBCF derivatization make the method efficient for diagnostics of folate and cobalamin status as well as for screening of amino acidic metabolites in body fluids.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a kyseliny alkansulfonové $7 D017738
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kyselina listová $x krev $7 D005492
- 650 _2
- $a formiáty $7 D005561
- 650 _2
- $a plynová chromatografie s hmotnostně spektrometrickou detekcí $x metody $x normy $7 D008401
- 650 _2
- $a homocystein $x analýza $7 D006710
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kyselina methylmalonová $x analýza $7 D008764
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a sulfhydrylové sloučeniny $x chemie $7 D013438
- 650 _2
- $a vitamin B 12 $x krev $7 D014805
- 700 1_
- $a Hušek, Petr $7 xx0077501
- 700 1_
- $a Zahradníčková, Helena. $7 xx0303910
- 773 0_
- $w MED00000337 $t Analytical chemistry $g Roč. 376, č. 1 (2008), s. 94-102 $x 0003-2700
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110324080229 $b ABA008
- 991 __
- $a 20120506231015 $b ABA008
- 999 __
- $a ok $b bmc $g 833384 $s 697987
- BAS __
- $a 3
- BMC __
- $a 2008 $b 376 $c 1 $d 94-102 $m Analytical chemistry $n Anal Chem $x MED00000337
- LZP __
- $a 2011-3B/vtme